Grifols Inc. Completes $1.1 Billion Acquisition Financing
Date: 01/21/11
Cahill represented Deutsche Bank, Nomura International, BBVA Securities, BNP Paribas, HSBC and Morgan Stanley as joint book-running managers in the Rule 144A/Reg S Offering of $1,100,000,000 of 8.25% Senior Notes due 2018 by Giant Funding Corp. The offering closed into escrow and, subject to the conditions set forth in the escrow agreement, the obligations under the notes will be assumed by Grifols Inc., a subsidiary of Grifols S.A., a Spanish-based pharmaceutical and chemical company, and the proceeds will be used to partially finance the acquisition of Talecris Biotherapeutics.